MAGEC3 and ovarian carcinoma: In an independent, model-building cohort and a further validation cohort, MAGEC3 was identified as a candidate prognostic biomarker associated with ovarian cancer with the potential for predictive marker-based treatment strategies based on targeting cases with high expression.